Prevalence of Helicobacter pylori antibodies in long-term dialysis patients

Nephrology

Volumn 9, Issue 2, 2004, Pages 73-76

  Nakajima, Fumitaka ^a,d   Sakaguchi, Masahiro ^a   Oka, Hiroshi ^a   Kawase, Yoshio ^b   Shibahara, Nobuhisa ^c   Inoue, Toru ^c   Ueda, Haruhiko ^d   Katsuoka, Yoji ^d  

^a Moriguchi Keijinkai Hospital   (Japan)

^b MATSUSHITA MEMORIAL HOSPITAL   (Japan)

^c Blood Purification Center   (Japan)

^d OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Dialysis; End stage renal disease; Helicobacter pylori; Prevalence

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; IMMUNOGLOBULIN G;

ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DIALYSIS; DISEASE ASSOCIATION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INCIDENCE; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; AGE FACTORS; AGED; ANTIBODIES, BACTERIAL; FEMALE; HELICOBACTER PYLORI; HISTAMINE H2 ANTAGONISTS; HUMANS; MALE; MIDDLE AGED; RENAL DIALYSIS; TIME FACTORS;

EID: 1942500151     PISSN: 13205358     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2004.00239.x     Document Type: Article

References (12)

1. Milito O, Taccone-Gallucci M, Brancaleone C. The gastrointestinal tract in uremic patients on long-term hemodialysis. Kidney Int. 1985; 17: 157-60.
2. 13C urea breath test for detection of Helicobacter pylori infection. J. Clin. Microbiol. 1996; 34: 1147-52.
3. Fabrizi F, Martin P, Dixit V et al. Epidemiology of Helicobacter pylori in chronic haemodialysis patients using the new RIBA H. pylori SIA. Nephrol. Dial. Transplant. 1999; 14: 1929-33.
4. Yildiz A, Erkoc R, Sever MS et al. The prognostic importance of severity and type of post-transplant proteinuria. Clin. Transplant. 1999; 13: 241-4.
5. Luzza F, Imeneo M, Maletta M et al. Helicobacter pylori-specific IgG in chronic haemodialysis patients: Relationship of hypergastrinaemia to positive serology. Nephrol. Dial. Transplant. 1996; 1: 120-4.
6. Tokushima H. Role of Helicobacter pylori in gastro-duodenal mucosal lesions in patients with end-stage renal disease under dialysis treatment. Jpn J. Nephrol. 1995; 37: 503-10.
7. Munoz de Bustillo E, Sanchez Tomero JA et al. Eradication and follow-up of Helicobacter pylori infection in hemodialysis patients. Nephron 1998; 79: 55-60.
8. Huang JJ, Huang CJ, Ruaan MK, Chen KW, Yen TS, Sheu BS. Diagnostic efficacy of (13) C-urea breath test for Helicobacter pylori infection in hemodialysis patients. Am. J. Kidney Dis. 2000; 36: 124-9.
9. Ozgur O, Boyacioglu S, Ozdogan M, Gur G, Telatar H, Haberal M. Helicobacter pylori infection in haemodialysis patients and renal transplant recipients. Nephrol. Dial. Transplant. 1997; 12: 289-91.
10. Chiba N, Rao BV, Rademaker JW, Hunt RH. Meta-analysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylori. Am. J. Gastroenterol. 1992; 87: 1716-27.
11. Nakajima F, Sakaguchi M, Amemoto K, Oka H, Shibahara N, Ueda H, Katsuoka Y. Helicobacter pylori in patients receiving long-term dialysis. Am. J. Nephrol. 2002; 22: 468-72.
12. Wang YL, Sheu BS, Huang JJ, Yang HB. Noninvasive stool antigen assay can effectively screen Helicobacter pylori infection and assess success of eradication therapy in hemodialysis patients. Am. J. Kidney Dis. 2001; 38: 98-103.